Call for papers for Drug, Healthcare and Patient Safety: medication safety in geriatric populations
Drug, Healthcare and Patient Safety is currently inviting submissions for it’s latest Article Collection titled ‘medication safety in geriatric populations.’
With the increase in older adults globally, there is a greater need to understand medication safety issues, as older adults are often excluded in randomized trials. In addition, the complexity of chronic care for older adults often leads to polypharmacy and potentially inappropriate medication use, which can result in drug-induced diseases, adverse drug reactions, drug interactions, cognitive impairment, falls, hospitalization and mortality. This Article Collection aims to address these challenges by bringing together the latest research and clinical insights to improve medication safety in geriatric populations.
Medication safety is crucial in geriatric populations due to the increased susceptibility of older adults to adverse drug reactions and the potential for drug interactions. The aging process can alter pharmacokinetics and pharmacodynamics, making older adults more prone to medication-related problems. Ensuring medication safety in this vulnerable population is essential to prevent medication-related morbidity and mortality and associated healthcare burden such as hospitalization, healthcare costs, and health-related quality of life for older adults.
To help raise the profile of this important area of research, Drug Healthcare and Patient Safety is publishing a timely Article Collection on medication safety in geriatric populations. Potential topics include, but are not limited to, the following:
-
- Medicated-related problems in older adults
- Polypharmacy and medication management
- Inappropriate medication use
- Drug-drug and drug-disease interactions
- Prescribing cascade and deprescribing
- As an open-access journal, your paper will be made available to anyone in the world to download for free directly from the Dove website.
- Although Drug, Healthcare and Patient Safety receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Drug, Healthcare and Patient Safety has a quicker turnaround time than this. Generally peer review is complete within 3–4 weeks and the editor’s decision within 2–14 days of this. It is therefore very rare to have to wait more than 6 weeks for the first editorial decision.
- Many authors have found that the peer reviewer’s comments substantially add to their final papers.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 31 December 2025. Please submit your manuscript to Dove Medical Press, quoting the promo code ZIZRU to indicate that your submission is for consideration in this Article Collection.
Please reach out to the journal Commissioning Editor Haoyang Yi ([email protected]) for more information on article submission.
PubMed Central
Drug, Healthcare and Patient Safety is indexed on PubMed Central (title abbreviation: Drug Healthc Patient Saf). All published papers in this journal are submitted to PubMed for indexing straight away.